Company: SNWV
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001628280-25-014141
Chunk: 68

Company: SANUWAVE Health, Inc.
Filing Date: 2025-03-20
Form: 10-K
Item: Item 15
Chunk 68
---
Item 15.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 

1.All financial statements

The following financial statements are included in this Annual Report on Form 10-K in Item 8 of Part II:

PageConsolidated financial statementsReport of Independent Registered Public Accounting Firm (PCAOB ID: 688)F-1Consolidated Balance Sheets as of December 31, 2024 and 2023F-3Consolidated Statements of Comprehensive Loss for the years ended December 31, 2024 and 2023F-4Consolidated Statements of Stockholders’ Deficit for the years ended December 31, 2024 and 2023F-5Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023F-6Notes to Consolidated Financial StatementsF-7

2.Financial statement schedules

No schedules are required because either the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements or the notes thereto.

The exhibits below are furnished or filed and, as applicable, are incorporated by reference herein as part of this Annual Report on Form 10-K.

Exhibit No.Description2.1Agreement and Plan of Merger, dated as of August 23, 2023, by and among SEP Acquisition Corp., SEP Acquisition Holdings Inc., and SANUWAVE Health, Inc. (Incorporated by reference to Exhibit 2.1 to the Form 8-K filed with the SEC on August 23, 2023). 2.2Amendment Number One to Agreement and Plan of Merger, dated as of February 27, 2024, by and between SEP Acquisition Corp. and SANUWAVE Health, Inc. (Incorporated by reference to Exhibit 2.1 to the Form 8-K filed with the SEC on February 28, 2024). 2.3Amendment Number Two to Agreement and Plan of Merger, dated as of April 25, 2024, by and between SEP Acquisition Corp. and SANUWAVE Health, Inc. (Incorporated by reference to Exhibit 10.1 to the Form 8-K filed with the SEC on April 26, 2024). 2.4Amended Number Three to Agreement and Plan of Merger, dated as of May